Abstract
S983 Baseline Demographics and Disease Characteristics of Patients With Ulcerative Colitis Who Responded to Vedolizumab at Week 6
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.14309/01.ajg.0000860572.50435.a2
Publication Date: Oct 1, 2022 |
S983 Baseline Demographics and Disease Characteristics of Patients With Ulcerative Colitis Who Responded to Vedolizumab at Week 6
Join us for a 30 min session where you can share your feedback and ask us any queries you have